Top

Quality of Life Research

Gepubliceerd in:

01-08-2013

What is the use? Application of the short form (SF) questionnaires for the evaluation of treatment effects

Auteurs: Aline J. Pelle, Nina Kupper, Floortje Mols, Peter de Jonge

Gepubliceerd in: Quality of Life Research | Uitgave 6/2013

Abstract

Background

Health status has evolved as a clinical outcome measure that is of great interest in medical care. However, there is still debate about the appropriateness of scoring algorithms for the often used short form questionnaires. Therefore, our aim was to evaluate the consequences of the traditional scoring procedure based on orthogonal factor rotation for clinical applications by (a) re-evaluating the results of randomized controlled trials (RCTs) on the effectiveness of antidepressants in improving health status in cardiac patients and (b) comparing empirical evidence on depression and health status using orthogonal and oblique factor rotation (alternative scoring method) in a community sample and a heart failure (HF) sample.

Methods

This is a systematic literature review and cross-sectional analysis among 1,598 community sample participants and 282 HF patients.

Results

Orthogonal rotation artificially forces the mental component summary (MCS) and physical component summary (PCS) to be unrelated, which is illustrated in two of the three included RCTs. Two RCTs showed improvements in MCS, but no improvement in PCS over time. Cross-sectional analysis in the two datasets showed that employing the alternative scoring algorithm resulted in higher negative correlations of MCS and PCS with depression, and a gradual decline in MCS with each decile of decline in PCS.

Conclusion

Our data showed that appropriate carefulness is needed when calculating and interpreting summary scores. The traditional scoring algorithm seems inappropriate to objectively evaluate the effects of interventions on both the MCS and the PCS. Awareness in the design and evaluation of interventions using these outcomes is warranted.

vorige artikel Health-related quality of life in relation to walking habits and fitness: a population-based study of 75-year-olds

volgende artikel Health-related quality of life and supportive care in patients with rare long-term neurological conditions

Ware, J. E, Jr, & Sherbourne, C. D. (1992). The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Medical Care, 30(6), 473–483.PubMedCrossRef

Ware, J, Jr, Kosinski, M., & Keller, S. D. (1996). A 12-Item short-form health survey: Construction of scales and preliminary tests of reliability and validity. Medical Care, 34(3), 220–233.PubMedCrossRef

Ware, J. E, Jr, Kosinski, M., & Keller, S. D. (1994). Sf-36® physical and mental health health summary scales: A user’s manual. Boston, MA: The Health Institute.

Mols, F., Pelle, A. J., & Kupper, N. (2009). Normative data of the SF-12 health survey with validation using post myocardial infarction patients in the Dutch population. Quality of Life Research, 18(4), 403–414.PubMedCrossRef

Windsor, T. D., Rodgers, B., Butterworth, P., Anstey, K. J., & Jorm, A. F. (2006). Measuring physical and mental health using the SF-12: Implications for community surveys of mental health. The Australian and New Zealand Journal of Psychiatry, 40(9), 797–803.PubMedCrossRef

Farivar, S. S., Cunningham, W. E., & Hays, R. D. (2007). Correlated physical and mental health summary scores for the SF-36 and SF-12 health survey, V.I. Health and Quality of Life Outcomes, 5, 54.PubMedCrossRef

Taft, C., Karlsson, J., & Sullivan, M. (2001). Do SF-36 summary component scores accurately summarize subscale scores? Quality of Life Research, 10(5), 395–404.PubMedCrossRef

Fleishman, J. A., Selim, A. J., & Kazis, L. E. Deriving SF-12v2 physical and mental health summary scores: A comparison of different scoring algorithms. Quality of Life Research, 19(2), 231–241.

Anagnostopoulos, F., Niakas, D., & Tountas, Y. (2009). Comparison between exploratory factor-analytic and SEM-based approaches to constructing SF-36 summary scores. Quality of Life Research, 18(1), 53–63.PubMedCrossRef

10.

Ware, J. E, Jr, Kosinski, M., Bayliss, M. S., McHorney, C. A., Rogers, W. H., & Raczek, A. (1995). Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: Summary of results from the medical outcomes study. Medical Care, 33(4 Suppl), AS264–AS279.PubMed

11.

Nortvedt, M. W., Riise, T., Myhr, K. M., & Nyland, H. I. (2000). Performance of the SF-36, SF-12, and RAND-36 summary scales in a multiple sclerosis population. Medical Care, 38(10), 1022–1028.PubMedCrossRef

12.

Thombs, B. D., & Hudson, M. (2008). Problems using aggregate scores of the medical outcomes study 36-item short form health survey in knee and hip osteoarthritis: Possible solutions. Osteoarthritis Cartilage, 16(11), 1431–1432; author reply 1430.

13.

Simon, G. E., Revicki, D. A., Grothaus, L., & Vonkorff, M. (1998). SF-36 summary scores: Are physical and mental health truly distinct? Medical Care, 36(4), 567–572.PubMedCrossRef

14.

van den Brink, R. H., van Melle, J. P., Honig, A., Schene, A. H., Crijns, H. J., Lambert, F. P., et al. (2002). Treatment of depression after myocardial infarction and the effects on cardiac prognosis and quality of life: Rationale and outline of the myocardial infarction and depression-intervention trial (MIND-IT). American Heart Journal, 144(2), 219–225.PubMed

15.

Lesperance, F., Frasure-Smith, N., Koszycki, D., Laliberte, M. A., van Zyl, L. T., Baker, B., et al. (2007). Effects of citalopram and interpersonal psychotherapy on depression in patients with coronary artery disease: The canadian cardiac randomized evaluation of antidepressant and psychotherapy efficacy (CREATE) trial. JAMA, 297(4), 367–379.PubMedCrossRef

16.

Appels, A., Bar, F., van der Pol, G., Erdman, R., Assman, M., Trijsburg, W., et al. (2005). Effects of treating exhaustion in angioplasty patients on new coronary events: Results of the randomized exhaustion intervention trial (EXIT). Psychosomatic Medicine, 67(2), 217–223.PubMedCrossRef

17.

Glassman, A. H., O’Connor, C. M., Califf, R. M., Swedberg, K., Schwartz, P., Bigger, J. T, Jr, et al. (2002). Sertraline treatment of major depression in patients with acute MI or unstable angina. JAMA, 288(6), 701–709.PubMedCrossRef

18.

Jolly, K., Taylor, R. S., Lip, G. Y., Davies, M., Davis, R., Mant, J., et al. (2009). A randomized trial of the addition of home-based exercise to specialist heart failure nurse care: The birmingham rehabilitation uptake maximisation study for patients with congestive heart failure (BRUM-CHF) study. European Journal of Heart Failure, 11(2), 205–213.PubMedCrossRef

19.

Zwisler, A. D., Soja, A. M., Rasmussen, S., Frederiksen, M., Abedini, S., Appel, J., et al. (2008). Hospital-based comprehensive cardiac rehabilitation versus usual care among patients with congestive heart failure, ischemic heart disease, or high risk of ischemic heart disease: 12-month results of a randomized clinical trial. American Heart Journal, 155(6), 1106–1113.PubMedCrossRef

20.

Frizelle, D. J., Lewin, R. J., Kaye, G., Hargreaves, C., Hasney, K., Beaumont, N., et al. (2004). Cognitive-behavioural rehabilitation programme for patients with an implanted cardioverter defibrillator: A pilot study. British Journal of Health Psychology, 9(Pt 3), 381–392.PubMedCrossRef

21.

Karavidas, A., Parissis, J., Arapi, S., Farmakis, D., Korres, D., Nikolaou, M., et al. (2008). Effects of functional electrical stimulation on quality of life and emotional stress in patients with chronic heart failure secondary to ischaemic or idiopathic dilated cardiomyopathy: A randomised, placebo-controlled trial. European Journal of Heart Failure, 10(7), 709–713.PubMedCrossRef

22.

Michalsen, A., Grossman, P., Lehmann, N., Knoblauch, N. T., Paul, A., Moebus, S., et al. (2005). Psychological and quality-of-life outcomes from a comprehensive stress reduction and lifestyle program in patients with coronary artery disease: Results of a randomized trial. Psychotherapy and Psychosomatics, 74(6), 344–352.PubMedCrossRef

23.

Angermann, C. E., Gelbrich, G., Stork, S., Fallgatter, A., Deckert, J., Faller, H., et al. (2007). Rationale and design of a randomised, controlled, multicenter trial investigating the effects of selective serotonin re-uptake inhibition on morbidity, mortality and mood in depressed heart failure patients (MOOD-HF). European Journal of Heart Failure, 9(12), 1212–1222.PubMedCrossRef

24.

Jiang, W., O’Connor, C., Silva, S. G., Kuchibhatla, M., Cuffe, M. S., Callwood, D. D., et al. (2008). Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): A randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure. American Heart Journal, 156(3), 437–444.PubMedCrossRef

25.

Investigators, E. (2001). Enhancing recovery in coronary heart disease (ENRICHD) study intervention: Rationale and design. Psychosomatic Medicine, 63(5), 747–755.

26.

Rollman, B. L., Belnap, B. H., LeMenager, M. S., Mazumdar, S., Houck, P. R., Counihan, P. J., et al. (2009). Telephone-delivered collaborative care for treating post-CABG depression: A randomized controlled trial. JAMA, 302(19), 2095–2103.PubMedCrossRef

27.

Freedland, K. E., Skala, J. A., Carney, R. M., Rubin, E. H., Lustman, P. J., Davila-Roman, V. G., et al. (2009). Treatment of depression after coronary artery bypass surgery: A randomized controlled trial. Archives of General Psychiatry, 66(4), 387–396.PubMedCrossRef

28.

Swenson, J. R., O’Connor, C. M., Barton, D., Van Zyl, L. T., Swedberg, K., Forman, L. M., et al. (2003). Influence of depression and effect of treatment with sertraline on quality of life after hospitalization for acute coronary syndrome. The American Journal of Cardiology, 92(11), 1271–1276.PubMedCrossRef

29.

Denollet, J., Martens, E. J., Smith, O. R., & Burg, M. M. (2010). Efficient assessment of depressive symptoms and their prognostic value in myocardial infarction patients. Journal of Affective Disorders, 120(1–3), 105–111.PubMedCrossRef

30.

Spinhoven, P., Ormel, J., Sloekers, P. P., Kempen, G. I., Speckens, A. E., & Van Hemert, A. M. (1997). A validation study of the hospital anxiety and depression scale (HADS) in different groups of Dutch subjects. Psychological Medicine, 27(2), 363–370.PubMedCrossRef

31.

Mendes de Leon, C. F., Czajkowski, S. M., Freedland, K. E., Bang, H., Powell, L. H., Wu, C., Burg, M. M., DiLillo, V., Ironson, G., Krumholz, H. M., Mitchell, P., & Blumenthal, J. A. (2006). The effect of a psychosocial intervention and quality of life after acute myocardial infarction: the enhancing recovery in coronary heart disease (ENRICHD) clinical trial. Journal of Cardiopulmonary Rehabilitation, 26(1), 9–13; quiz 14–15.

32.

Ware, J. E., & Kosinski, M. (2001). Interpreting SF-36 summary health measures: A response. Quality of Life Research, 10(5), 405–413; discussion 415–420.

33.

Wilson, D., Parsons, J., & Tucker, G. (2000). The SF-36 summary scales: Problems and solutions. Sozial- und Präventivmedizin, 45(6), 239–246.PubMedCrossRef

34.

Hann, M., & Reeves, D. (2008). The SF-36 scales are not accurately summarised by independent physical and mental component scores. Quality of Life Research, 17(3), 413–423.PubMedCrossRef

Titel: What is the use? Application of the short form (SF) questionnaires for the evaluation of treatment effects
Auteurs: Aline J. Pelle
Nina Kupper
Floortje Mols
Peter de Jonge
Publicatiedatum: 01-08-2013
Uitgeverij: Springer Netherlands
Gepubliceerd in: Quality of Life Research / Uitgave 6/2013
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-012-0266-8

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Background

Methods

Results

Conclusion

Log in om toegang te krijgen

Andere artikelen Uitgave 6/2013

Measurement invariance of the Functional Assessment of Cancer Therapy—Colorectal quality-of-life instrument among modes of administration

The impact of persistent visually disabling vitreous floaters on health status utility values

Longitudinal analysis of the relationship between PTSD symptom clusters, cigarette use, and physical health-related quality of life

Type D, anxiety and depression in association with quality of life in patients with Parkinson’s disease and patients with multiple sclerosis

Self-reported medical morbidity among informal caregivers of chronic illness: the case of cancer

Prevention of quality-of-life deterioration with light therapy is associated with changes in fatigue in women with breast cancer undergoing chemotherapy